医学
特应性皮炎
母乳喂养
过敏性
哮喘
食物过敏
儿科
怀孕
牛奶过敏
过敏
疾病
母乳喂养
母乳
心理干预
消除饮食
低过敏性
婴儿配方奶粉
免疫学
内科学
过敏原
化学
精神科
生物
生物化学
遗传学
作者
Frank R. Greer,Scott H. Sicherer,A. Wesley Burks
出处
期刊:Pediatrics
[American Academy of Pediatrics]
日期:2007-12-31
卷期号:121 (1): 183-191
被引量:1090
标识
DOI:10.1542/peds.2007-3022
摘要
This clinical report reviews the nutritional options during pregnancy, lactation, and the first year of life that may affect the development of atopic disease (atopic dermatitis, asthma, food allergy) in early life. It replaces an earlier policy statement from the American Academy of Pediatrics that addressed the use of hypoallergenic infant formulas and included provisional recommendations for dietary management for the prevention of atopic disease. The documented benefits of nutritional intervention that may prevent or delay the onset of atopic disease are largely limited to infants at high risk of developing allergy (ie, infants with at least 1 first-degree relative [parent or sibling] with allergic disease). Current evidence does not support a major role for maternal dietary restrictions during pregnancy or lactation. There is evidence that breastfeeding for at least 4 months, compared with feeding formula made with intact cow milk protein, prevents or delays the occurrence of atopic dermatitis, cow milk allergy, and wheezing in early childhood. In studies of infants at high risk of atopy and who are not exclusively breastfed for 4 to 6 months, there is modest evidence that the onset of atopic disease may be delayed or prevented by the use of hydrolyzed formulas compared with formula made with intact cow milk protein, particularly for atopic dermatitis. Comparative studies of the various hydrolyzed formulas also indicate that not all formulas have the same protective benefit. There is also little evidence that delaying the timing of the introduction of complementary foods beyond 4 to 6 months of age prevents the occurrence of atopic disease. At present, there are insufficient data to document a protective effect of any dietary intervention beyond 4 to 6 months of age for the development of atopic disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI